BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15000822)

  • 1. The reduction of Raf-1 protein by phosphorothioate ODNs and siRNAs targeted to the same two mRNA sequences.
    Lou TF; Gray CW; Gray DM
    Oligonucleotides; 2003; 13(5):313-24. PubMed ID: 15000822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid oligomer duplexes formed with phosphorothioate DNAs: CD spectra and melting temperatures of S-DNA.RNA hybrids are sequence-dependent but consistent with similar heteronomous conformations.
    Hashem GM; Pham L; Vaughan MR; Gray DM
    Biochemistry; 1998 Jan; 37(1):61-72. PubMed ID: 9425026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense recognition of the HER-2 mRNA: effects of phosphorothioate substitution and polyamines on DNA.RNA, RNA.RNA, and DNA.DNA duplex stability.
    Venkiteswaran S; Vijayanathan V; Shirahata A; Thomas T; Thomas TJ
    Biochemistry; 2005 Jan; 44(1):303-12. PubMed ID: 15628872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of polyamines on the stability of RNA-DNA hybrids containing phosphodiester and phosphorothioate oligodeoxyribonucleotides.
    Antony T; Thomas T; Shirahata A; Thomas TJ
    Biochemistry; 1999 Aug; 38(33):10775-84. PubMed ID: 10451373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short hairpin DNA analogous to miR-125b inhibits C-Raf expression, proliferation, and survival of breast cancer cells.
    Hofmann MH; Heinrich J; Radziwill G; Moelling K
    Mol Cancer Res; 2009 Oct; 7(10):1635-44. PubMed ID: 19825990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of divalent cations on the conformation of phosphorothioate oligodeoxynucleotides: a circular dichroism study.
    Patil SD; Rhodes DG
    Nucleic Acids Res; 2000 Jun; 28(12):2439-45. PubMed ID: 10871378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules.
    Opalinska JB; Kalota A; Gifford LK; Lu P; Jen KY; Pradeepkumar PI; Barman J; Kim TK; Swider CR; Chattopadhyaya J; Gewirtz AM
    Nucleic Acids Res; 2004; 32(19):5791-9. PubMed ID: 15514112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient stabilization of phosphodiester (PO), phosphorothioate (PS), and 2'-O-methoxy (2'-OMe) DNA·RNA hybrid duplexes by amino sugars.
    Charles I; Davis E; Arya DP
    Biochemistry; 2012 Jul; 51(27):5496-505. PubMed ID: 22639785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
    Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
    Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of human vascular smooth muscle cells to Raf-1 antisense oligodeoxynucleotides: cellular responses and pharmacodynamic implications.
    Schumacher C; Cioffi CL; Sharif H; Haston W; Monia BP; Wennogle L
    Mol Pharmacol; 1998 Jan; 53(1):97-104. PubMed ID: 9443936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular dynamics of antisense oligonucleotides and short interfering RNAs.
    Lee LK; Dunham BM; Li Z; Roth CM
    Ann N Y Acad Sci; 2006 Oct; 1082():47-51. PubMed ID: 17145924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides.
    Bertram J; Killian M; Brysch W; Schlingensiepen KH; Kneba M
    Biochem Biophys Res Commun; 1994 Apr; 200(1):661-7. PubMed ID: 7909438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
    Normand N; Valamanesh F; Savoldelli M; Mascarelli F; BenEzra D; Courtois Y; Behar-Cohen F
    Mol Vis; 2005 Mar; 11():184-91. PubMed ID: 15761390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of c-Raf expression induces apoptosis in tumor cells.
    Lau QC; Brüsselbach S; Müller R
    Oncogene; 1998 Apr; 16(14):1899-902. PubMed ID: 9583688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
    Shinozuka K; Okamoto T; Matsukura M; Sawai H
    Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design.
    Lu ZJ; Mathews DH
    Nucleic Acids Res; 2008 Jun; 36(11):3738-45. PubMed ID: 18483081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal effect of Raf-1/Mdr-1 siRNAs co-transfection on multidrug resistance in KBv200 cell line.
    Dong Y; Shao S; Hu J; Yang P
    Oral Oncol; 2009 Nov; 45(11):991-7. PubMed ID: 19631573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
    Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
    Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
    Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
    Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.